Cargando…

InflammamiR-146a and -155 Plasma Levels are Associated with Clinical Efficacy of Risankizumab Treatment in Psoriatic Patients: Pilot Study

INTRODUCTION: The key role of microRNAs (miRNAs) in the pathogenesis of psoriasis has been extensively discussed in the literature. Increasing evidence suggests that the analysis of miRNA levels may constitute an innovative approach for exploring the clinical efficacy of anti-inflammatory therapies...

Descripción completa

Detalles Bibliográficos
Autores principales:	Diotallevi, Federico, Matacchione, Giulia, d’Agostino, Giovanni Marco, Gioacchini, Helena, Campanati, Anna, Sabbatinelli, Jacopo, Olivieri, Fabiola, Offidani, Annamaria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2023
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10264314/ https://www.ncbi.nlm.nih.gov/pubmed/37198526 http://dx.doi.org/10.1007/s13555-023-00931-1

Ejemplares similares

Saliva and Oral Diseases
por: Martina, Emanuela, et al.
Publicado: (2020)

Therapeutic Use of Botulinum Neurotoxins in Dermatology: Systematic Review
por: Martina, Emanuela, et al.
Publicado: (2021)

Treatment of Moderate to Severe Psoriasis during the COVID-19 Pandemic: Lessons Learned and Opportunities
por: Campanati, Anna, et al.
Publicado: (2022)

Bullous Pemphygoid and Novel Therapeutic Approaches
por: D’Agostino, Giovanni Marco, et al.
Publicado: (2022)

Decreased serum levels of the inflammaging marker miR-146a are associated with clinical non-response to tocilizumab in COVID-19 patients
por: Sabbatinelli, Jacopo, et al.
Publicado: (2021)

Psoriasis as an Immune-Mediated and Inflammatory Systemic Disease: From Pathophysiology to Novel Therapeutic Approaches
por: Campanati, Anna, et al.
Publicado: (2021)

New Insight into the Molecular Pathomechanism and Immunomodulatory Treatments of Hidradenitis Suppurativa
por: Molinelli, Elisa, et al.
Publicado: (2023)

Fluorescence‐guided surgery for non‐melanoma and melanoma skin cancer: Case series and a brief review of the literature
por: Ivan, Bobyr, et al.
Publicado: (2021)

Efficacy and Safety of Botulinum Toxin B in Focal Hyperhidrosis: A Narrative Review
por: Campanati, Anna, et al.
Publicado: (2023)

Population Pharmacokinetics and Exposure–Response Analyses for Risankizumab in Patients with Active Psoriatic Arthritis
por: Thakre, Neha, et al.
Publicado: (2022)

Extracellular vesicle-shuttled miRNAs: a critical appraisal of their potential as nano-diagnostics and nano-therapeutics in type 2 diabetes mellitus and its cardiovascular complications
por: Prattichizzo, Francesco, et al.
Publicado: (2021)

Circulating biomarkers of inflammaging as potential predictors of COVID-19 severe outcomes
por: Sabbatinelli, Jacopo, et al.
Publicado: (2022)

miRNAs, Mesenchymal Stromal Cells and Major Neoplastic and Inflammatory Skin Diseases: A Page Being Written: A Systematic Review
por: Di Vincenzo, Mariangela, et al.
Publicado: (2023)

Vitiligo, from Pathogenesis to Therapeutic Advances: State of the Art
por: Diotallevi, Federico, et al.
Publicado: (2023)

Treatment of Moderate-to-Severe Psoriasis in the Presence of Kaposi's Varicelliform Eruption
por: Campanati, Anna, et al.
Publicado: (2019)

New and Old Horizons for an Ancient Drug: Pharmacokinetics, Pharmacodynamics, and Clinical Perspectives of Dimethyl Fumarate
por: Matteo, Paolinelli, et al.
Publicado: (2022)

Skin, Autoimmunity and Inflammation: A Comprehensive Exploration through Scientific Research
por: Diotallevi, Federico, et al.
Publicado: (2023)

Risankizumab for psoriasis
Publicado: (2020)

Mesenchymal Stem Cells and Psoriasis: Systematic Review
por: Diotallevi, Federico, et al.
Publicado: (2022)

Efficacy of calcipotriol plus betamethasone dipropionate foam on psoriatic skin lesions beyond human eyes: An observational study
por: Anna, Campanati, et al.
Publicado: (2022)

Author index volumes 146–155 1992
Publicado: (1992)

Subject index volumes 146–155 1992
Publicado: (1992)

Vaccines Against SARS-CoV-2 in Psoriasis Patients on Immunosuppressive Therapy: Implications of Vaccination Nationwide Campaign on Clinical Practice in Italy
por: Diotallevi, Federico, et al.
Publicado: (2021)

Curcumin, Polydatin and Quercetin Synergistic Activity Protects from High-Glucose-Induced Inflammation and Oxidative Stress
por: Matacchione, Giulia, et al.
Publicado: (2022)

The Challenge Arising from New Knowledge about Immune and Inflammatory Skin Diseases: Where We Are Today and Where We Are Going
por: Campanati, Anna, et al.
Publicado: (2022)

A Data-Mining Approach to Identify NF-kB-Responsive microRNAs in Tissues Involved in Inflammatory Processes: Potential Relevance in Age-Related Diseases
por: Micolucci, Luigina, et al.
Publicado: (2023)

The Combination of Natural Molecules Naringenin, Hesperetin, Curcumin, Polydatin and Quercetin Synergistically Decreases SEMA3E Expression Levels and DPPIV Activity in In Vitro Models of Insulin Resistance
por: Scarpa, Emanuele-Salvatore, et al.
Publicado: (2023)

Pro-Osteogenic and Anti-Inflammatory Synergistic Effect of Orthosilicic Acid, Vitamin K2, Curcumin, Polydatin and Quercetin Combination in Young and Senescent Bone Marrow-Derived Mesenchymal Stromal Cells
por: Giordani, Chiara, et al.
Publicado: (2023)

Reticulated acanthoma with sebaceous differentiation
por: Molinelli, Elisa, et al.
Publicado: (2021)

Efficacy and safety of risankizumab for active psoriatic arthritis: 52-week results from the KEEPsAKE 2 study
por: Östör, Andrew, et al.
Publicado: (2022)

Efficacy and safety of risankizumab for active psoriatic arthritis: 52-week results from the KEEPsAKE 1 study
por: Kristensen, Lars Erik, et al.
Publicado: (2022)

The Association between Single Nucleotide Polymorphisms, including miR-499a Genetic Variants, and Dyslipidemia in Subjects Treated with Pharmacological or Phytochemical Lipid-Lowering Agents
por: Giuliani, Angelica, et al.
Publicado: (2022)

Mesenchymal Stem Cells Profile in Adult Atopic Dermatitis and Effect of IL4-IL13 Inflammatory Pathway Inhibition In Vivo: Prospective Case-Control Study
por: Campanati, Anna, et al.
Publicado: (2022)

Erythrodermic Psoriasis Managed with Risankizumab
por: Alajlan, Abdulmajeed, et al.
Publicado: (2022)

Randomized, Double-Blind, Placebo-Controlled Trial to Test the Effects of a Nutraceutical Combination Monacolin K-Free on the Lipid and Inflammatory Profile of Subjects with Hypercholesterolemia
por: Protic, Olga, et al.
Publicado: (2022)

Saliva Proteomics as Fluid Signature of Inflammatory and Immune-Mediated Skin Diseases
por: Campanati, Anna, et al.
Publicado: (2021)

Latest combination therapies in psoriasis: Narrative review of the literature
por: Diotallevi, Federico, et al.
Publicado: (2022)

Prognostic value of soluble ST2, high-sensitivity cardiac troponin, and NT-proBNP in type 2 diabetes: a 15-year retrospective study
por: Sabbatinelli, Jacopo, et al.
Publicado: (2022)

Senescent macrophages in the human adipose tissue as a source of inflammaging
por: Matacchione, Giulia, et al.
Publicado: (2022)

Meta‐Analyses of Clinical Efficacy of Risankizumab and Adalimumab in Chronic Plaque Psoriasis: Supporting Evidence of Risankizumab Superiority
por: Witjes, Han, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_hgtq7v3ljo3e42ds98eff36mlm